Purpose: To evaluate whether or not brain single photon emission computed tomography (SPECT) with Tc-99m MIBI or Tc-99m ECD (ethyl cysteinate dimer) can detect any abnormality in patients with definite multiple sclerosis (MS). We then compared these values with the results of T1, T2, and fluid-attenuated inversion recovery in magnetic resonance imaging (MRI). Materials and Methods: A total of 16 patients with proved MS were enrolled in the study, and the MRI with and without gadolinium contrast and also brain SPECT with Tc-99m MIBI (8 cases) or Tc-99m ECD (8 other cases) were performed. Results: MRI studies was performed in 16 patients (13 women and 3 men, aged 16 -38 years) and an average of 10.47, 3.7, 5.3, 1.7, and 0.9 lesions was found in respect in periventricular white matter, juxtacortical white matter, corpus callosum, cerebellar peduncles, and brainstem, whereas brain SPECT with Tc-99m MIBI or Tc-99m ECD detected no abnormality. In addition, 6 cases had some degree of contrast enhancement. Conclusions: It seems that brain SPECT with Tc-99m MIBI or Tc-99m ECD would not improve this insufficiency. The small sizes of some plaques, particularly in chronic atrophic form of lesions, and the possibility of deeper anatomic positions of plaques can explain to some extent why the MS lesions were impossible to delineate on brain scan, although additional studies are needed. 2 Gean-Marton et al have also proposed that lesions in midsagittal long repetition time (TR)/short echo time (TE) images and involvement of corpus callosum are highly specific for MS rather than other periventricular WM disorders. 3 Fast spin-echo (FSE), fluid-attenuated inversion recovery (FLAIR) FSE, and short tau inversion recovery FSE are among the other modifications to MRI, which ameliorate the sensitivity and specificity of indicated MS plaques.
Key4 A combinational set of textural features application in image volumetric interpretation has also shown to be more accurate in distinguishing MS plaques from the normal appearing WM and normal WM.
5The most challenging concern regarding the MRI application for MS evaluation is the commonly poor correlation between MRI indicated levels of disease and clinical manifestations or expanded disability status scale in which the degree of lesions reported in MRI is always worse than what the extent of clinical symptoms are. 6 Although early anticipation of potential deterioration of disease is important for clinical management, 7 little prognostic capability of MRI where it cannot predict the relapse or consequent burden is another insufficiency of this procedure.8 Intracortical lesions which have been shown to be abundant in MS patients and may elicit cognitive deficit usually remains obscure on MR imaging. 9 Abnormal brain scan is reported in MS and other demyelinating disorders. Gize and Mishkin have described focal abnormalities with 203 Hg-chlormerodrin or 99mTcO4 brain scan in 36% of cases with acute MS 10 and Miller and Potsaid have also reported a case of MS with vascular infiltration in whic...